Previous literature has demonstrated that a primary mechanism by which AHR ligands limit excessive immune responses in autoimmune disorders is by regulating a dysbiotic microbiota and promoting the production of the SCFAs (Ji and Qu, 2019; Busbee et al., 2020). The gene discussed is AHR; the disease is autoimmune disease.